QantX
  • Home
  • Invest
  • Team
  • Strategy
  • Portfolio
  • News
  • Contact
  • Investor Portal
Select Page
Molydyn wins a Blavatnik Prize for Innovation

Molydyn wins a Blavatnik Prize for Innovation

by Harry Alexander | Oct 31, 2022 | Innovation, Innovation Prize

QantX has awarded Matthew Bone, CEO of Molydyn, a £25,000 Blavatnik Prize for Innovation to support commercial trials and further development of his newly released Atlas platform. Computational tools have shown extreme benefits for biological sciences and drug...
SensefulAI awarded a Blavatnik Prize for Innovation

SensefulAI awarded a Blavatnik Prize for Innovation

by Harry Alexander | Oct 6, 2022 | Innovation, Innovation Prize

In July, we soft launched the Blavatnik Prize for Innovation to support founders in the South West to commercialise their technology. The goal of the prize fund is to help bridge the gap between a conceptually proven technology and equity investment, by providing...
Next Entries »

Latest Posts

  • SENISCA: treating age-related diseases with ground-breaking science
  • Lutra Health: integrating community and hospital eyecare
  • QantX leads £600K investment round to speed up innovation in the quantum industry
  • Supporting the Full Innovation Stack: From Lab Discovery to Global Impact
  • QantX partners with the SETsquared Partnership universities on new £300m investment vehicle

enquiries@qantx.co.uk  

Investor Area

QantX (Reference number: 954072) is an Appointed Representative of Kin Capital Partners LLP (FRN: 656789). Kin Capital Partners LLP (trading as Kin Fund Services) is authorised and regulated by the Financial Conduct Authority.

© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.